| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/09/2009 | WO2008085266A3 Radioimmunotherapy and imaging of tumor cells that express viral antigens |
| 04/09/2009 | WO2008070666A3 Compositions and methods to treat cancer with cpg rich dna and cupredoxins |
| 04/09/2009 | WO2006089218A3 Methods and compositions for modulating angiogenesis |
| 04/09/2009 | WO2006079068A3 Compositions and methods for studying and treating inflammatory diseases and disorders |
| 04/09/2009 | WO2006073446A3 Peptide-mediated protein transduction into cells the hematopoietic lineage |
| 04/09/2009 | WO2005086775A3 Lumen-exposed molecules and methods for targeted delivery |
| 04/09/2009 | WO2005026320A3 Entrapped stem cells and uses thereof |
| 04/09/2009 | WO2004110360A3 Proteoglycan degrading mutants for treatment of cns |
| 04/09/2009 | US20090093867 Light activated gene transduction using long wavelength ultraviolet light for cell targeted gene delivery |
| 04/09/2009 | US20090093622 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis |
| 04/09/2009 | US20090093433 SENSE mRNA THERAPY |
| 04/09/2009 | US20090093428 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis |
| 04/09/2009 | US20090093413 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/09/2009 | US20090093412 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/09/2009 | US20090093407 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 04/09/2009 | US20090093055 Islet Cells from Human Embryonic Stem Cells |
| 04/09/2009 | US20090093040 producer cell which produces virions that contain the vector; comprises a minimal vector construct, a minimal packaging construct, and a minimal viral surface protein expression construct |
| 04/09/2009 | US20090092995 Method for Identifying Within a Mammal a DNA encoding a Physiologically Active Polypeptide |
| 04/09/2009 | US20090092963 Method for combined parallel agent delivery and electroporation for cell structures an use thereof |
| 04/09/2009 | US20090092659 containing protonated/acidified nucleic acids that are bactericidal; wound sealant, surgical drape , skin substitute |
| 04/09/2009 | US20090092627 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 04/09/2009 | US20090092623 Promoter |
| 04/09/2009 | US20090092613 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 04/09/2009 | US20090092594 Mammalian genes involved in viral infection and tumor suppression |
| 04/09/2009 | US20090092592 Methionyl tRNA Synthetase Polynucleotides |
| 04/09/2009 | US20090092589 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/09/2009 | US20090092579 Novel method for down-regulation of amyloid |
| 04/09/2009 | DE19543553B4 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 04/09/2009 | DE102007048591A1 Implantat und Verfahren zu seiner Herstellung Implant and method for its preparation |
| 04/09/2009 | CA2701561A1 Widespread gene delivery to motor neurons using peripheral injection of aav vectors |
| 04/09/2009 | CA2701542A1 Attenuated invasive e. coli strains and applications thereof as intracellular vector for therapeutic molecule |
| 04/09/2009 | CA2701215A1 Articular cartilage gene therapy with recombinant vector encoding bmp-7 |
| 04/09/2009 | CA2694091A1 Self complementary aav-mediated delivery of interfering rna molecules to treat or prevent ocular disorders |
| 04/08/2009 | EP2045331A1 Attenuated invasive E. coli strains and their applications as an intracellular vector for therapeutic molecules |
| 04/08/2009 | EP2045322A1 Double-muscling in mammals |
| 04/08/2009 | EP2045260A1 Replication deficient RNA viruses as vaccines |
| 04/08/2009 | EP2044200A1 Uses and compositions comprising mirnas |
| 04/08/2009 | EP2044199A2 Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy |
| 04/08/2009 | EP2043662A2 Methods and compositions for treating disease |
| 04/08/2009 | EP1539808B1 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 04/08/2009 | EP1476468B9 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 04/08/2009 | EP1274854B1 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
| 04/08/2009 | EP0877758B1 PURIFIED SR-p70 PROTEIN |
| 04/08/2009 | CN101405298A Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use |
| 04/08/2009 | CN101405033A Enhanced production of infectious parvovirus vectors in insect cells |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101402942A PolyLyse-HSP70 fusion protein film modified intestinal cancer cytoma vaccine and method of producing the same |
| 04/08/2009 | CN100475953C Pancreatic stem cells |
| 04/08/2009 | CN100475846C Improved secretion of neublastin |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475268C Recombinant adenovirus lyophilized preparation and preparing method thereof |
| 04/07/2009 | US7514550 Sense and antisense regions; kits for gene silencing |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514530 Peptide carrier for delivering siRNA into mammalian cells |
| 04/07/2009 | US7514416 Suppressing growth of pancreatic tumors or cancer cells having a K-ras gene point mutation by administering directly to the tumor cells an adenoviral vector having a DNA sequence encoding human interferon alpha and linked to a promoter and an antisense K-ras expressing vector |
| 04/07/2009 | US7514252 Tumor/cancer therapy/drugs for infecting/killing cells with mutant virus; comprises deletion or inactivating mutation in both copies of gene, at least one copy is reintroduced under transcriptional control of cell-specific and/or tumor-specific promoter; capable of delivering transgene cytotoxic to tumor |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514233 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases |
| 04/07/2009 | US7514224 Arrays of PDZ domain polypeptides |
| 04/07/2009 | US7514221 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/07/2009 | US7514207 Administering compound (antibodies, ATP analogs) that inhibits p-21 activated kinase (PAK) activity and/or merlin phosphorylation; drug screening; neurofibromatosis |
| 04/07/2009 | US7514098 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 04/07/2009 | US7514089 Mutant Salmonella species with genetically engineered MSBB gene, expresses altered lipid, has reduced inductino of tumor necrosis factor and increased sensitivity to chelating agents; as antitumor agent |
| 04/07/2009 | US7514074 Cardiac muscle regeneration using mesenchymal stem cells |
| 04/07/2009 | CA2410065C Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/07/2009 | CA2313704C Recombinant nodavirus compositions and methods |
| 04/07/2009 | CA2311643C Compositions and methods for inducing gene expression |
| 04/07/2009 | CA2208519C Viral vector complexes having adapters of predefined valence |
| 04/07/2009 | CA2175332C Haemophilus transferrin receptor genes |
| 04/07/2009 | CA2100472C Inherited and somatic mutations of apc gene in colerectal cancer of humans |
| 04/02/2009 | WO2009042910A2 Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis |
| 04/02/2009 | WO2009042798A1 Methods for treating fibrosis by modulating cellular senescence |
| 04/02/2009 | WO2009042677A2 Stat3 inhibiting compositions and methods |
| 04/02/2009 | WO2009039743A1 Sirnas useful for inhibiting expression of tyrosinase gene, the compositions comprising the sirnas and their uses |
| 04/02/2009 | WO2009039657A1 High concentration chitosan-nucleic acid polyplex compositions |
| 04/02/2009 | WO2009039628A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 04/02/2009 | WO2009020905A3 Ultraconserved regions encoding ncrnas |
| 04/02/2009 | WO2009014382A3 Cxcl11 adjuvant compositions and uses thereof |
| 04/02/2009 | WO2008141282A3 Materials and methods for foxp3 tumor suppression |
| 04/02/2009 | WO2006042146A3 Multifunctional nanoparticles conjugates and their use |
| 04/02/2009 | WO2006028492A3 hC1Q/TNF7 AND USES THEREOF |
| 04/02/2009 | WO2005077006A3 Methods and compositions for detecting and treating retinal diseases |
| 04/02/2009 | WO2005067632A3 Lipid compositions and use thereof |
| 04/02/2009 | WO2005047477A3 Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai |
| 04/02/2009 | WO2005033292A3 Methods of establishing intercellular communication in an endothelial cell layer and uses thereof |
| 04/02/2009 | WO2004080394A3 Stat3 antagonists and their use as vaccines against cancer |
| 04/02/2009 | US20090088563 Consisting of a sense and antisense region that form a duplex region; and from zero to one overhang regions; gene silencing, gene expression inhibition; gene therapy, drug discovery; cancer, Alzheimer's disease, diabetes |
| 04/02/2009 | US20090088555 44 Human Secreted Proteins |
| 04/02/2009 | US20090088398 Recombinant adenoviral vectors and methods of use |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087851 Lineage-Restricted Neuronal Precursors |
| 04/02/2009 | US20090087474 Therapeutic use of growth factors,nsg29 and nsg31 |
| 04/02/2009 | US20090087437 Methods and compositions relating to the regulation of apoptosis by muc1 and bh3-containing proapoptotic proteins |
| 04/02/2009 | US20090087417 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/02/2009 | US20090087416 novel B7-H3 and B7-H4 polypeptides useful for co-stimulating T cells, vectors containing the nucleic acid molecules, and cells containing the vectors |
| 04/02/2009 | US20090087413 Self-complementary aav-mediated delivery of interfering rna molecules to treat or prevent ocular disorders |
| 04/02/2009 | US20090087412 Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression |
| 04/02/2009 | DE102007044487A1 Verwendung des umgekehrten Zelldifferenzierungsprogramms (OCDP) zur Behandlung degenerierter, im pathologischen Zustand befindlicher Organe Using the reverse cell differentiation program (OCDP) for the treatment of degenerate, properties under pathological state organs |
| 04/02/2009 | CA2700842A1 High concentration chitosan-nucleic acid polyplex compositions |
| 04/02/2009 | CA2700808A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |